智通财经APP获悉，摩根大通发布研报称，根据现金流量折现法(DCF)予上美股份(02145)最新目标价为 114港元，对应2026/27年30倍及24倍市盈率，维持"增持"评级。该行预计，集团将凭借多品牌组合、研 发实力、全渠道和不断提升的品牌价值，以及随着内地美妆行业快速增长，将进一步提升市场份额。 2025年上半年集团业绩稳健，该行对集团的长期愿景持乐观态度。该行将2025-27年盈利预测上调1- 5%，较市场普遍预期高出3-8%。 ...

摩根大通发布研报称，根据现金流量折现法(DCF)予上美股份(02145)最新目标价为114港元，对应 2026/27年30倍及24倍市盈率，维持"增持"评级。该行预计，集团将凭借多品牌组合、研发实力、全渠 道和不断提升的品牌价值，以及随着内地美妆行业快速增长，将进一步提升市场份额。2025年上半年集 团业绩稳健，该行对集团的长期愿景持乐观态度。该行将2025-27年盈利预测上调1-5%，较市场普遍预 期高出3-8%。 ...

Core Insights - The 25th China International Investment and Trade Fair was held in Xiamen from September 8 to 11, attracting over 120 countries and regions, showcasing the "Shenzhen Outbound e-Station" as a key player in overseas service platforms [1][3] Group 1: Event Overview - The fair is China's only national-level exhibition focused on promoting investment, featuring government agencies, international organizations, multinational companies, and investment institutions [1] - The Guangdong Provincial Department of Commerce recognized the leading exploration of outbound service systems by Qianhai and Shenzhen [3] Group 2: Participation and Collaboration - Shenzhen Outbound e-Station adopted a dual approach of "group exhibition + special promotion," collaborating with 13 cross-industry companies to enhance business interactions and showcase comprehensive service capabilities [5][6] - A special promotion event was held to share practical insights and compliance guidelines for companies looking to expand internationally [6] Group 3: Achievements and Outcomes - Shenzhen Outbound e-Station facilitated significant cooperation outcomes for participating companies, enhancing domestic links and opening international market opportunities [9] - Notable collaborations included Fuzhou Dahua Intelligent Technology connecting with core suppliers, and partnerships formed by Xiamen Yujia Technology with various brands to enhance product offerings [9] Group 4: Customized Services - The platform introduced "one enterprise, one policy" customized services to address specific outbound needs across various sectors, including new energy, forestry, agriculture, and cultural industries [11] Group 5: International Cooperation and Network Expansion - Shenzhen Outbound e-Station is actively expanding international cooperation channels, collaborating with the Greater Bay Area Import and Export Commercial Association to promote comprehensive service platforms [12] - Plans include partnerships with international organizations to facilitate trade and investment opportunities in Europe and Uzbekistan [12] Group 6: Platform Strengths - The platform integrates online and offline services, offering a one-stop government service with 70 public service items and a robust online service website with 15,000 registered users [15] - It focuses on four key stages of outbound planning, preparation, operation, and safety, covering product, investment, and service outbound scenarios [16]

Core Viewpoint - The international beauty brand Schwarzkopf has faced criticism for using the term "Virgin Hair" in its product labeling, which some consumers find disrespectful towards women. The company has acknowledged the issue and is taking steps to rectify the translation error in its product descriptions [1][9]. Product Description - The product in question is Schwarzkopf's professional cold perm kit, suitable for normal hair and lightly damaged hair. The labeling describes normal hair as "Virgin Hair (untreated with chemicals)" and lightly damaged hair as having been treated with oxidizing dyes or exposed to sunlight, resulting in porous and rough hair [3][4]. - The cold perm product promises to provide long-lasting curls, smooth and shiny hair post-treatment, and features a low-odor formula with added chlorophyll for a fresh perm experience [3][4]. Company Response - Schwarzkopf's official customer service has expressed regret over the inaccurate translation and the discomfort it caused consumers. The brand has initiated a comprehensive update of its product descriptions [7][9]. - On September 11, Schwarzkopf's official Weibo account issued an apology to the public, acknowledging the feedback regarding the translation and stating that a thorough investigation was launched. The company emphasized that the translation failed to convey the original meaning accurately [9].

Core Viewpoint - The article discusses the regulatory actions taken against the "Big Mouth Doctor" account for spreading misleading information about companies, particularly targeting Juzi Biological, which faced significant market backlash due to allegations of product falsification [3][4][6]. Summary by Sections Regulatory Actions - The National Internet Information Office announced the second batch of typical cases in the "Clear and Optimized Business Network Environment" campaign, which included the banning of the "Big Mouth Doctor" account for distorting company information and disrupting market order [3][6]. Incident Overview - In May, the "Big Mouth Doctor" account published a report alleging that Juzi Biological's product, Kefu Mei, was fraudulent, claiming it could not detect collagen [4][5]. - Juzi Biological responded with multiple statements asserting the accuracy of their products and the inaccuracy of the claims made by the "Big Mouth Doctor" [5][6]. Market Impact - The controversy led to a significant drop in Juzi Biological's stock price, with a reported decline of 10% over two days [6]. - The incident occurred during the "618" shopping festival, raising concerns about potential consumer backlash and its impact on sales [9]. Company Performance - Despite the controversy, Juzi Biological's financial performance remained strong, with a revenue increase from 2.375 billion to 5.539 billion yuan from 2022 to 2024, and net profit rising from 1 billion to 2.062 billion yuan [8]. - The company reported a revenue of 3.113 billion yuan for the first half of 2025, a year-on-year increase of 22.5%, with Kefu Mei contributing significantly to this growth [9]. Industry Context - The collagen market in China is projected to grow rapidly, with a compound annual growth rate of 44.93%, reaching an estimated market size of 219.38 billion yuan by 2030 [10]. - Competitors in the beauty industry, such as Marubi and L'Oreal, are also increasing their investments in this segment, indicating a competitive landscape [10].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [6][7]. Core Views - The company is transitioning into a high-end global beauty group driven by its own brands and CP (Contract Production) brands, with a focus on high-end and global expansion [6][7]. - The financial forecast indicates a recovery trend in performance, with expected net profits of 258 million, 331 million, and 398 million yuan for 2025, 2026, and 2027 respectively, reflecting significant growth rates [6][7]. Financial Data and Profit Forecast - Total revenue (in million yuan) is projected to be 4,237 in 2024, 2,500 in H1 2025, 4,630 in 2025E, 4,996 in 2026E, and 5,382 in 2027E, with year-on-year growth rates of -5.7%, 9.0%, 9.3%, 7.9%, and 7.7% respectively [2]. - Net profit attributable to the parent company (in million yuan) is expected to be 110 in 2024, 123 in H1 2025, 258 in 2025E, 331 in 2026E, and 398 in 2027E, with year-on-year growth rates of -62.6%, 16.5%, 134.9%, 28.1%, and 20.2% respectively [2]. - Earnings per share (in yuan/share) are forecasted to be 0.28 in 2024, 0.32 in H1 2025, 0.66 in 2025E, 0.85 in 2026E, and 1.02 in 2027E [2]. Business Model and Strategy - The company operates a dual business model of self-owned brands and CP brands, with a strong focus on high-end brand development and global market penetration [6][21]. - The self-owned brand matrix includes high-end brands like EDB, PA, and RV, alongside popular brands like YUNIFANG and DSD, which cater to diverse consumer needs [6][21]. - The company has established a robust digital platform for international beauty brands, collaborating with over 50 international brands across various categories [6][21]. Competitive Advantages - The company has a concentrated and stable shareholding structure, with the founder holding approximately 43.1% of the shares, ensuring strong governance [24]. - The management team possesses extensive experience in the beauty industry, enhancing the company's strategic and operational capabilities [27]. - The company has demonstrated a significant improvement in profitability, with gross margins increasing from 52.07% in 2021 to 64.61% in 2025H1, driven by the high-end brand strategy [32].

Investment Rating - The report initiates coverage with a "Buy" rating for the company [3][7]. Core Insights - The company is transitioning into a high-end global beauty group driven by its own brands and CP (Contract Production) brands, with a focus on high-end market penetration and digital transformation [6][18]. - The financial forecast indicates a significant recovery in net profit, with expected growth rates of 134.9%, 28.1%, and 20.2% for the years 2025 to 2027 [7][39]. Financial Data and Profit Forecast - Total revenue (in million yuan) is projected to be 4,630 in 2025, with a year-on-year growth rate of 9.3% [2]. - Net profit attributable to the parent company is expected to reach 258 million yuan in 2025, reflecting a substantial increase of 134.9% compared to the previous year [2]. - Earnings per share are forecasted to be 0.66 yuan in 2025, with a PE ratio of 33 [2]. Business Model and Strategy - The company operates a dual business model comprising self-owned brands and CP brands, with a strong emphasis on high-end product offerings [18][24]. - The self-owned brand matrix includes high-end brands like EDB, PA, and RV, alongside popular mass-market brands such as YU NI BANG and DA SHUI DI [24][51]. - The CP brand strategy involves partnerships with over 50 international brands, enhancing the company's market presence and product diversity [24][25]. Competitive Advantages - The company has established a comprehensive brand matrix and a robust digital marketing strategy, leveraging platforms like Douyin for sales [6][10]. - Strong R&D capabilities support the development of unique raw materials and technologies, enhancing product differentiation [6][39]. - The management team possesses extensive industry experience, contributing to strategic decision-making and operational efficiency [28][32]. Growth Catalysts - Anticipated growth in high-end brand sales, optimization of the agency business structure, and effective channel collaboration are expected to drive revenue growth [10][39]. - The successful integration of acquired brands and the expansion of digital channels are key factors for future performance [6][10].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Insights - The company reported a revenue of 2.59 billion yuan for H1 2025, representing a year-on-year growth of 31.3%. The net profit attributable to shareholders was 670 million yuan, up 36.1% year-on-year. The adjusted profit reached 672 million yuan, with a growth of 32% and an adjusted profit margin of 26% [2][4]. Summary by Sections Revenue Breakdown - In H1 2025, the revenue from different product categories was as follows: makeup 1.42 billion yuan, skincare 1.09 billion yuan, fragrance 11 million yuan, and training schools 67 million yuan, with year-on-year growth rates of +31%, +33%, no growth for fragrance, and -6% for training schools. Excluding training schools, total product sales grew by 32.7% [5]. Product Performance - Within the makeup category, the base makeup segment performed strongly, with retail sales of caviar cushion and light sensation powder exceeding 200 million yuan each. The skincare segment saw classic products like caviar masks achieving retail sales of over 600 million yuan (up 33% year-on-year) and black cream exceeding 200 million yuan. New high-end products are being introduced steadily [5]. Channel Performance - Online sales continued to grow significantly, with revenues of 1.3 billion yuan (up 39% year-on-year), while offline sales reached 1.22 billion yuan (up 27% year-on-year). The repurchase rates improved by 2.6 percentage points for online and 1.6 percentage points for offline channels [5]. Profitability - The net profit margin for H1 2025 reached 26%, an increase of 0.9 percentage points year-on-year. This was attributed to a 0.7 percentage point decline in gross margin, primarily due to lower margins in makeup and training schools, and a significant optimization in expense ratios [5]. Future Outlook - The company is expected to maintain a clear growth trend in the short to medium term, driven by a robust pipeline of mid-tier products, high elasticity in e-commerce channels, and continuous improvement in offline store efficiency. The long-term potential includes category expansion, collaboration with more high-end brands, and international market entry [5]. The projected adjusted net profits for 2025-2027 are 1.25 billion, 1.57 billion, and 1.92 billion yuan, with corresponding P/E ratios of 35.9, 28.4, and 23.3 times [5].

Core Viewpoint - Huaxi Biological is continuously downsizing its C-end functional skincare business, specifically shutting down the Runxiquan brand, which was not a major contributor to its revenue and profit [1][2]. Group 1: Business Strategy and Focus - The closure of Runxiquan is part of Huaxi Biological's strategy to focus on its core business and main brands, emphasizing that collagen is not a strategic focus for the company [1][2]. - The company has faced significant pressure from a sharp decline in the performance of its C-end functional skincare brands, with revenue from this segment dropping from over 70% to 40.36% of total revenue by mid-2025 [3]. - Huaxi Biological's chairman has publicly stated the need for corporate restructuring and a return to a startup mentality, highlighting issues with over-reliance on external marketing resources [3]. Group 2: Market Position and Challenges - The company positions itself as a "synthetic biotechnology company," differentiating itself from other domestic beauty brands that rely heavily on consumer sales [4]. - Despite the challenges in the C-end market, Huaxi Biological maintains a competitive edge through its B-end raw materials and medical terminal segments [4]. - The company has diversified its raw material offerings beyond hyaluronic acid, including ingredients like Ectoin and PDRN, but hyaluronic acid remains its core product [6]. Group 3: Brand Management and Market Perception - Huaxi Biological's main brands, including Runbaiyan and Kuadi, have overlapping market positions and unclear differentiation in consumer perception, which complicates their market strategies [9][10]. - The company has shifted from a strategy of aggressive brand expansion to a more focused approach, indicating a need to clarify which brands are core and which are experimental [10][11]. - The overall trend in the domestic beauty industry reflects a shift towards brand structure rebalancing, as companies seek to maintain main brand advantages while managing the performance of sub-brands [11].

Core Insights - The appointment of Dr. Karl Lintner as the Chief Scientific Advisor of Up Beauty marks a significant step in the company's global research and development strategy, integrating global scientific expertise with local market insights [3][10]. Group 1: Dr. Karl Lintner's Background and Role - Dr. Lintner is recognized as a pioneer in peptide technology within the cosmetics industry, having a PhD in biochemistry from the University of Vienna and over ten years of experience in peptide research [4][5]. - His contributions include successfully introducing peptide patent technology into cosmetics, transforming the beauty technology landscape [5][11]. - Lintner's collaboration with Up Beauty aligns with the company's vision of building a global research framework, enhancing its international cooperation capabilities [5][9]. Group 2: Strategic Implications for Up Beauty - The partnership with Dr. Lintner is expected to enhance Up Beauty's global competitiveness in peptide technology, providing a platform for innovation and collaboration with top international research institutions [13][14]. - This collaboration signifies a shift in the Chinese beauty industry towards a more systematic approach to research and development, moving from passive technology acquisition to proactive collaboration [16][17]. - Up Beauty aims to establish a "Chinese Original Ingredient" certification system, enhancing its role in setting industry standards and increasing its global influence [18][19]. Group 3: Market Context and Future Outlook - The Chinese beauty market is experiencing a surge in demand for effective products, positioning Up Beauty as a leader in connecting technological advancements with consumer needs [9][10]. - The collaboration is anticipated to accelerate the development of innovative peptide-based products, setting a benchmark for domestic brands in the anti-aging segment [11][13]. - The integration of global scientific insights with local market understanding is expected to elevate China's position in the global beauty research landscape [19][20].